These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7930289)

  • 1. Does heart transplantation confer additional benefit over medical therapy to patients who have waited > 6 months for heart transplantation?
    Kao W; McGee D; Liao Y; Heroux AL; Mullen GM; Johnson MR; Costanzo MR
    J Am Coll Cardiol; 1994 Nov; 24(6):1547-51. PubMed ID: 7930289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe right ventricular dysfunction is an independent predictor of pre- and post-transplant mortality among candidates for heart transplantation.
    Ravis E; Theron A; Mancini J; Jaussaud N; Morera P; Chalvignac V; Guidon C; Grisoli D; Gariboldi V; Riberi A; Habib G; Mouly-Bandini A; Collart F
    Arch Cardiovasc Dis; 2017 Mar; 110(3):139-148. PubMed ID: 28117247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time.
    Aaronson KD; Mancini DM
    J Am Coll Cardiol; 1999 Apr; 33(5):1189-95. PubMed ID: 10193715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens.
    Stevenson LW; Hamilton MA; Tillisch IH; Moriguchi JD; Kobashigawa JA; Creaser JA; Drinkwater D; Laks H
    J Am Coll Cardiol; 1991 Oct; 18(4):919-25. PubMed ID: 1894865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
    Krakauer H; Lin MJ; Bailey RC
    J Heart Lung Transplant; 2005 Jun; 24(6):680-9. PubMed ID: 15949727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HeartMate left ventricular assist device as bridge to heart transplantation.
    Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
    Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single centre experience with prolonged waiting time on transplant list with "high-urgency" status.
    Heim C; Nooh E; Kondruweit M; Weyand M; Tandler R
    Thorac Cardiovasc Surg; 2013 Apr; 61(3):251-4. PubMed ID: 23015278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in patient selection for heart transplantation.
    Kubo SH; Ormaza SM; Francis GS; Holmer SC; Olivari MT; Bolman RM; Shumway SJ
    J Am Coll Cardiol; 1993 Mar; 21(4):975-81. PubMed ID: 8450168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients removed from the heart transplant waiting list.
    Shah NR; Rogers JG; Ewald GA; Pasque MK; Geltman EM; Bailey MS; Moazami N
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1481-5. PubMed ID: 15116011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    Levine TB; Levine AB; Goldberg D; Narins B; Goldstein S; Lesch M
    J Heart Lung Transplant; 1996 Mar; 15(3):297-303. PubMed ID: 8777214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation.
    Smits JM; de Vries E; De Pauw M; Zuckermann A; Rahmel A; Meiser B; Laufer G; Reichenspurner H; Strueber M
    J Heart Lung Transplant; 2013 Sep; 32(9):873-80. PubMed ID: 23628111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of patients removed from a transplant waiting list for medical improvement: implications for organ allocation and transplantation for status 2 patients.
    Hoercher KJ; Nowicki ER; Blackstone EH; Singh G; Alster JM; Gonzalez-Stawinski GV; Starling RC; Young JB; Smedira NG
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1159-66. PubMed ID: 18455599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
    Rickenbacher PR; Trindade PT; Haywood GA; Vagelos RH; Schroeder JS; Willson K; Prikazsky L; Fowler MB
    J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenging Pathway Toward Heart Transplant Listing for Adult Congenital Heart Disease Patients.
    Lo Rito M; Poretti G; Varrica A; Negura D; Micheletti A; Chessa M; Giamberti A
    Artif Organs; 2018 Sep; 42(9):911-917. PubMed ID: 30094862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of blood group on mortality and waiting time before heart transplantation in the United kingdom: implications for equity of access.
    Hussey JC; Parameshwar J; Banner NR;
    J Heart Lung Transplant; 2007 Jan; 26(1):30-3. PubMed ID: 17234514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.